Zdrowie i gospodarka · 31/05/2013

FDA Releases Draft Guidance on Rheumatoid Arthritis Drug Development

The US Food and Drug Administration (FDA) has made available a draft guidance document outlining its principles for developing drug products to treat rheumatoid arthritis, a condition that affects millions of Americans, and revising its previous guidance on clinical development programs for RA treatments.